Hsinchu, Taiwan

Yi-Da Chung

This inventor holds 1 USPTO granted patent. Top assignee: National Tsing Hua University. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yi-Da Chung in Cardiovascular Disease Detection

Introduction

Yi-Da Chung is an accomplished inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of cardiovascular disease-related biomarkers. His innovative work has the potential to enhance early detection and treatment of cardiovascular conditions.

Latest Patents

Yi-Da Chung holds a patent for a test kit designed to detect the concentration of cardiovascular disease-related biomarkers. The patent, titled "Test kit for detecting concentration of cardiovascular disease-related biomarker and concentration detection method for detecting concentration of cardiovascular disease-related biomarker," includes a unique combination of aptamers. The first aptamer specifically binds to N-terminal pro-brain natriuretic peptide (NT-proBNP), the second to cardiac Troponin I (cTnI), and the third to fibrinogen. This innovative approach allows for accurate detection of critical biomarkers associated with cardiovascular diseases.

Career Highlights

Yi-Da Chung is affiliated with Tsinghua University, where he continues to advance research in medical diagnostics. His work is characterized by a commitment to improving healthcare outcomes through innovative technologies. His contributions have been recognized within the academic and medical communities.

Collaborations

Yi-Da Chung has collaborated with notable colleagues, including Gwo-Bin Lee and Anirban Sinha. These partnerships have fostered a collaborative environment that enhances research and development in the field of cardiovascular diagnostics.

Conclusion

Yi-Da Chung's innovative work in the detection of cardiovascular disease-related biomarkers represents a significant advancement in medical diagnostics. His contributions have the potential to improve patient outcomes and advance the field of cardiovascular health.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…